Invention Grant
- Patent Title: CD19 variants
-
Application No.: US16954002Application Date: 2018-12-14
-
Publication No.: US11891426B2Publication Date: 2024-02-06
- Inventor: Roy Lobb , Paul Rennert , Benjamin Hackel , Justin Klesmith
- Applicant: Aleta Biotherapeutics Inc. , Regents of The University of Minnesota
- Applicant Address: US MA Natick
- Assignee: Aleta Biotherapeutics Inc.,Regents of The University of Minnesota
- Current Assignee: Aleta Biotherapeutics Inc.,Regents of The University of Minnesota
- Current Assignee Address: US MA Natick; US MN Minneapolis
- Agency: Choate, Hall & Stewart LLP
- Agent Brenda Herschbach Jarrell; Rolando Medina
- International Application: PCT/US2018/065835 2018.12.14
- International Announcement: WO2019/118918A 2019.06.20
- Date entered country: 2020-06-15
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K16/32 ; A61K38/17 ; A61K39/395 ; A61K45/06 ; A61K39/00
Abstract:
CD19 variants, methods of identifying CD19 variants, and methods of using such CD19 variants, e.g., for treating cancer, are described.
Public/Granted literature
- US20210079060A1 CD19 VARIANTS Public/Granted day:2021-03-18
Information query
